Japanese Pearl Tree (Styphnolobium japonicum): An Exploration of Its Health Benefits

The Japanese pearl tree (Styphnolobium japonicum), an ornamental species native to East Asia, has long been valued in traditional Chinese medicine and is now gaining renewed attention for its multifaceted pharmacological potential. This review synthesizes the current knowledge of its bioactive compounds, particularly flavonoids such as genistein, rutoside, quercetin, and sophoricoside, and their broad-spectrum biological activities, including antioxidant, anti-inflammatory, antimicrobial, neuroprotective, and wound-healing effects. These phytochemicals contribute to protective mechanisms against oxidative stress, skin photoaging, osteoporosis, cardiovascular dysfunction, and metabolic disorders such as diabetes and obesity. Emerging evidence also supports their role in managing neurodegenerative and inflammatory diseases, alopecia, and postmenopausal symptoms. Despite its promise, the clinical translation of S. japonicum remains limited by gaps in safety, pharmacokinetic characterization, and standardized extraction protocols. Looking ahead, integrative approaches combining phytochemistry, pharmacogenomics, and advanced biotechnology are expected to unlock its full therapeutic potential. By bridging traditional use with precision medicine and sustainable bioprocessing, S. japonicum stands as a prospective source of next-generation plant-based therapeutics for modern healthcare.